Erratum: Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism of Corticosteroid Action in Allergic Disease (PLoS Med (2009) 6:5 (e1000076) DOI: 10.1371/journal.pmed.1000076);Suppression of GATA-3 nuclear import and phosphorylation: A novel mechanism of corticosteroid action in allergic disease

PLoS Medicine

Volumn 6, Issue 5, 2009, Pages

  Maneechotesuwan, Kittipong ^a,b   Yao, Xin ^a   Ito, Kazuhiro ^a   Jazrawi, Elen ^a   Usmani, Omar S ^a   Adcock, Ian M ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; INTERLEUKIN 4; KARYOPHERIN ALPHA; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TH2 CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ALPHA KARYOPHERINS; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ASTHMA; CELL LINE; CYTOKINES; DUAL SPECIFICITY PHOSPHATASE 1; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; PHOSPHORYLATION; RECEPTORS, GLUCOCORTICOID; TH2 CELLS;

EID: 66349134442     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/JOURNAL.PMED.1002657     Document Type: Erratum

References (43)

1. Umetsu DT, DeKruyff RH (2006) The regulation of allergy and asthma. Immunol Rev 212: 238-255. (Pubitemid 44116712)
2. Ray A, Cohn L (1999) Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J Clin Invest 104: 985-993. (Pubitemid 29536304)
3. Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE (2006) GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16: 3-10. (Pubitemid 43129303)
4. Lee GR, Fields PE, Flavell RA (2001) Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14: 447-459. (Pubitemid 32441597)
5. Takemoto N, Arai K, Miyatake S (2002) Cutting edge: the differential involvement of the N-finger of GATA-3 in chromatin remodeling and transactivation during Th2 development. J Immunol 169: 4103-4107. (Pubitemid 35178178)
6. Schwenger GT, Fournier R, Kok CC, Mordvinov VA, Yeoman D, et al. (2001) GATA-3 has dual regulatory functions in human interleukin-5 transcription. J Biol Chem 276: 48502-48509. (Pubitemid 37370764)
7. Lavenu-Bombled C, Trainor CD, Makeh I, Romeo PH, Max-Audit I (2002) Interleukin-13 gene expression is regulated by GATA-3 in T cells: role of a critical association of a GATA and two GATG motifs. J Biol Chem 277: 18313-18321. (Pubitemid 34952375)
8. Zhang DH, Yang L, Cohn L, Parkyn L, Homer R, et al. (1999) Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11: 473-482. (Pubitemid 29504202)
9. Finotto S, De Sanctis GT, Lehr HA, Herz U, Buerke M, et al. (2001) Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med 193: 1247-1260. (Pubitemid 32524775)
10. Pai SY, Truitt ML, Ho IC (2004) GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci U S A 101: 1993-1998. (Pubitemid 38229003)
11. Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, et al. (2004) Essential role of GATA-3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 279: 26983-26990. (Pubitemid 38812534)
12. Maneechotesuwan K, Xin Y, Ito K, Jazrawi E, Lee KY, et al. (2007) Regulation of Th2 Cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 178: 2491-2498. (Pubitemid 46233450)
13. Yagi R, Suzuki W, Seki N, Kohyama M, Inoue T, et al. (2002) The IL-4 production capability of different strains of naive CD4(+) T cells controls the direction of the T(h) cell response. Int Immunol 14: 1-11. (Pubitemid 34083392)
14. Yang Z, Gu L, Romeo PH, Bories D, Motohashi H, et al. (1994) Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol Cell Biol 14: 2201-2212.
15. Goldfarb DS, Corbett AH, Mason DA, Harreman MT, Adam SA (2004) Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol 14: 505-514. (Pubitemid 39209358)
16. Barnes PJ, Adcock IM (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14: 436-441. (Pubitemid 23362373)
17. Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. New Engl J Med 353: 1711-1723. (Pubitemid 41464710)
18. Barnes PJ (2006) How corticosteroids control inflammation. Br J Pharmacol 148: 245-254.
19. Picard D, Yamamoto KR (1987) Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 6: 3333-3340.
20. Carrigan A, Walther RF, Salem HA, Wu D, Atlas E, et al. (2007) An active nuclear retention signal in the glucocorticoid receptor functions as a strong inducer of transcriptional activation. J Biol Chem 282: 10963-10971. (Pubitemid 47100789)
21. Kumar S, Chaturvedi NK, Nishi M, Kawata M, Tyagi RK (2004) Shuttling components of nuclear import machinery involved in nuclear translocation of steroid receptors exit nucleus via exportin-1/CRM-1* independent pathway. Biochim Biophys Acta 1691: 73-77. (Pubitemid 38521268)
22. Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, et al. (1999) Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 19: 1025-1037. (Pubitemid 29046846)
23. Freedman ND, Yamamoto KR (2004) Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor. Mol Biol Cell 15: 2276-2286. (Pubitemid 38580645)
24. Pratt WB, Morishima Y, Murphy M, Harrell M (2006) Chaperoning of glucocorticoid receptors. Handb Exp Pharmacol 2006: 111-138.
25. Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, et al. (2005) HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 18: 601-607. (Pubitemid 40726236)
26. Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB (2007) Glucocorticoid receptor physiology. Rev Endocr Metab Disord 8: 321-330.
27. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, et al. (2005) FK506- binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280: 4609-4616. (Pubitemid 40288629)
28. Galigniana MD, Morishima Y, Gallay PA, Pratt WB (2004) Cyclophilin-A is bound through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor protein complex. J Biol Chem 279: 55754-55759. (Pubitemid 40066582)
29. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23: 4878-4884. (Pubitemid 3008389)
30. Zhang DH, Yang L, Ray A (1998) Differential responsiveness of the IL-5 and IL- 4 genes to transcription factor GATA-3. J Immunol 161: 3817-3821. (Pubitemid 28468953)
31. Masuda A, Yoshikai Y, Kume H, Matsuguchi T (2004) The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J Immunol 173: 5564-5573. (Pubitemid 39392143)
32. Li-Weber M, Krammer PH (2003) Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol 3: 534-543 (Pubitemid 37328673)
33. Jee YK, Gilmour J, Kelly A, Bowen H, Richards D, et al. (2005) Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA-3 signaling and involves histone deacetylase recruitment. J Biol Chem 280: 23243-23250. (Pubitemid 40853236)
34. Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, et al. (2005) Glucocorticoid receptor nuclear translocation in airway cells following inhaled combination therapy. Am J Respir Crit Care Med 172: 704-712. (Pubitemid 41324225)
35. Ito K, Jazrawi E, Cosio B, Barnes PJ, Adcock IM (2001) p65-activated histone acetyltransferase activity is repressed by glucocorticoids: Mifepristone fails to recruit HDAC2 to the p65/HAT complex. J Biol Chem 276: 30208-30215. (Pubitemid 37385102)
36. Ito K, Barnes PJ, Adcock IM (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-1b-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20: 6891-6903.
37. Daley-Yates PT, Tournant J, Kunka RL (2000) Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma. Clin.Pharmacokinet 39 (Suppl 1): 39-45.
38. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22: 7802-7811. (Pubitemid 35217291)
39. Furst R, Schroeder T, Eilken HM, Bubik MF, Kiemer AK, et al. (2007) MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J 21: 74-80. (Pubitemid 46052546)
40. Oh JW, Lee HB, Chung YH, Choi Y (2002) The effect of disodium cromoglycate, budesonide, and cyclosporin A on interleukin-4, interleukin-5, and interleukin-13 secretions in Der p I-stimulated T cells from house dust mite-sensitive atopic and nonatopic individuals. Allergy Asthma Proc 23: 109-115.
41. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, et al. (1995) IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol 7: 449-457.
42. Mori A, Kaminuma O, Ogawa K, Nakata A, Egan RW, et al. (2000) Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors. J Allergy Clin Immunol 106: S58-S64. (Pubitemid 30482836)
43. Erin EM, Leaker BR, Zacharasiewicz AS, Higgins LA, Williams TJ, et al. (2005) Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge. Allergy 60: 1524-1529. (Pubitemid 41654324)